Key result
The prevalence of apparent treatment-resistant hypertension in older Chinese patients was 5.97%, with male sex (OR 1.638) and type 2 diabetes (OR 1.371) identified as significant risk factors.
Why the study?
The prevalence and associated risk factors of apparent treatment-resistant hypertension (aTRH) in older people in China were unknown.
What is the prevalence and what are the risk factors of apparent treatment-resistant hypertension in older people in China?
Cross-Sectional (n=3,774)
What is the prevalence and what are the risk factors of apparent treatment-resistant hypertension in older people in China?
Apparent treatment-resistant hypertension affects approximately 6% of older hypertensive patients in China and is associated with male sex, diabetes, and a worse cardiovascular risk profile.
May inform risk stratification in older Chinese hypertensives; leaves open prospective validation of these associations.
The prevalence and associated risk factors of apparent treatment-resistant hypertension (aTRH) in older people in China is unknown. The aim of this study is to investigate the prevalence of aTRH in older people and describe the characteristics of older patients with aTRH. Using two-stage random clustering sampling, 3774 patients with hypertension aged ≥60–75 years were recruited between July 2012 and December 2015. The patients were divided into two groups: aTRH and non-aTRH groups according to their blood pressure (BP) levels, and whether or not they reached goal BP value. A multivariable logistical model was used to evaluate the risk factors of aTRH. The rate of antihypertensive treatment was 75.1%, BP control rate was 40.7%, and the prevalence of aTRH was 5.97% (169) according to the cross-sectional data among all the patients. The prevalence of aTRH patients taking 4 different classes of antihypertensive drugs or more was found to be 3.29% (93) in this study. Compared with non-aTRH patients, those with aTRH had a worse cardiovascular risk profile, including obesity (29.61% vs 20.53%, P = 0.005), hyperlipidemia (54.44% vs 46.66%, P = 0.050), type 2 diabetes mellitus (2-DM) (34.31% vs 25.64%, P = 0.013), and stroke (26.03% vs 19.26%, P = 0.032). After multivariable adjustment, logistic regression analyses showed that the risk factors of aTRH were male sex (OR 1.638; 95%CI 1.196–2.245, P = 0.002) and 2-DM (OR 1. 371; 95%CI 0.995–1.888, P = 0.049). Regular physical exercise (OR 0.696; 95%CI 0.505–0.960, P = 0.049) was a protective factor of aTRH. The prevalence of aTRH was 5.97% in older people in this cross-sectional study in China.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2018) conducted a cross-sectional in hypertension (n=3,774). Apparent treatment-resistant hypertension (aTRH) vs. Non-aTRH was evaluated on Prevalence of apparent treatment-resistant hypertension (aTRH). The prevalence of apparent treatment-resistant hypertension in older Chinese patients was 5.97%, with male sex (OR 1.638) and type 2 diabetes (OR 1.371) identified as significant risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: